Clinical Trial With Amway Affiliate
"Clinical Trial Agreement between Access Business Group and Neptune Technologies & Bioressources Inc."
MONTREAL, May 11 /CNW Telbec/ - Neptune Technologies & Bioressources Inc.(Neptune) is pleased to announce the conclusion of a clinical trial agreementwith Access Business Group LLC ("Access"), an affiliate of Amway Corp., toevaluate Neptune's NKO(TM) krill oil product. A successful clinical trial maylead Access and Neptune to a licensing agreement allowing Access to market aformulation with NKO(TM).
"This opens up the door to a mutually prosperous and successfulrelationship between Neptune and Access in numerous areas and markets"commented Dr. Tina Sampalis, Vice-President of Research & Development, atNeptune Technologies & Bioressources Inc. "We are enthusiastic about the factthat a company such as Access has decided to do a clinical trial with ourNKO(TM) product, added Dr. Sampalis.
MONTREAL, May 11 /CNW Telbec/ - Neptune Technologies & Bioressources Inc.(Neptune) is pleased to announce the conclusion of a clinical trial agreementwith Access Business Group LLC ("Access"), an affiliate of Amway Corp., toevaluate Neptune's NKO(TM) krill oil product. A successful clinical trial maylead Access and Neptune to a licensing agreement allowing Access to market aformulation with NKO(TM).
"This opens up the door to a mutually prosperous and successfulrelationship between Neptune and Access in numerous areas and markets"commented Dr. Tina Sampalis, Vice-President of Research & Development, atNeptune Technologies & Bioressources Inc. "We are enthusiastic about the factthat a company such as Access has decided to do a clinical trial with ourNKO(TM) product, added Dr. Sampalis.